Dr. Nathalie LeVasseur is an Assistant Clinical Professor in the Department of Medicine, Division of Medical Oncology at the University of British Columbia in Vancouver. She received her medical degree and completed her internal medicine residency at the University of Ottawa. She subsequently pursued a residency in medical oncology at the University of British Columbia and served as chief resident before completing a breast cancer clinical and research fellowship at the BC Cancer Agency. Dr. LeVasseur is the current chair of Breast Cancer Systemic Therapy in British Columbia, Canada, the co-lead of the Breast Cancer Clinical Trials Unit in Vancouver, and serves on the Canadian Cancer Trials Group (CCTG) IND Executive Committee, the BC Personalized Oncogenomics Steering Committee and the Breast Immuno-Oncology (BIO) Task Force of the National Cancer Institute Breast Cancer Steering Committee (BCSC). Her research focus is on the development of personalized oncology. Additionally, the improvement of patient outcomes and survivorship is an area of ongoing research interest. Dr. LeVasseur is a Fellow of the Royal College of Physicians and Surgeons of Canada. She holds professional memberships with the American Society of Clinical Oncology and the Canadian Association of Medical Oncology, among others. She has received academic achievement awards, including a Conquer Cancer ASCO Merit Award, NOYCIA Award, and a Coltman Scholars Award.
Dr. Nathalie LeVasseur is an Assistant Clinical Professor in the Department of Medicine, Division of Medical Oncology at the University of British Columbia in Vancouver. She received her medical degree and completed her internal medicine residency at the University of Ottawa. She subsequently pursued a residency in medical oncology at the University of British Columbia and served as chief resident before completing a breast cancer clinical and research fellowship at the BC Cancer Agency. Dr. LeVasseur is the current chair of Breast Cancer Systemic Therapy in British Columbia, Canada, the co-lead of the Breast Cancer Clinical Trials Unit in Vancouver, and serves on the Canadian Cancer Trials Group (CCTG) IND Executive Committee, the BC Personalized Oncogenomics Steering Committee and the Breast Immuno-Oncology (BIO) Task Force of the National Cancer Institute Breast Cancer Steering Committee (BCSC). Her research focus is on the development of personalized oncology. Additionally, the improvement of patient outcomes and survivorship is an area of ongoing research interest. Dr. LeVasseur is a Fellow of the Royal College of Physicians and Surgeons of Canada. She holds professional memberships with the American Society of Clinical Oncology and the Canadian Association of Medical Oncology, among others. She has received academic achievement awards, including a Conquer Cancer ASCO Merit Award, NOYCIA Award, and a Coltman Scholars Award.